new central bank searches

Evergrande Group and others were resumed execution by 320 million yuan. According to the information of legal proceedings, on December 11th, Evergrande Group Co., Ltd. added two pieces of resumption execution information, with a total execution amount of more than 322 million yuan, involving construction project contract disputes. The executors also included Hefei Yuetai Commercial Operation Management Co., Ltd. and Evergrande Real Estate Group Co., Ltd., and the enforcement court was the Baohe District People's Court in Hefei.The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.Yunnan Germanium Industry: downstream customers didn't feedback that the company germanium was directly used in quantum chip products. Some investors asked Yunnan Germanium Industry (002428) on the interactive platform: in quantum computing and quantum communication, germanium is widely used in the manufacturing process of quantum chips, which can achieve excellent performance. Excuse me, does the company have germanium products used in quantum chips? Yunnan Germanium Industry replied that at present, the downstream customers of the company have not reported to the company that it is directly used in this product.

The project of Chuangpu Instrument Industrial Park started in Hefei, with a total investment of 320 million yuan. According to the news of Hefei High-tech Zone Management Committee, on December 10th, the project of Chuangpu Instrument Industrial Park at the intersection of Caihong West Road and Peacock Terrace Road in Hefei High-tech Zone officially started. The total investment of the project is 320 million yuan, which is planned to be completed at one time and is expected to be put into use in the second half of 2027.Baijiayun received $15 million in financing. One-stop AI video technology service provider Baijiayun (NASDAQ：RTC) announced that the company had signed a series of important agreements with YA II PN, Ltd, a fund managed by Yorkville Advisors Global and LP. The company received $15 million in financing, and the down payment of $3 million was received on the signing date of the agreement.Treasury futures rose by 0.30%, the 30-year main contract rose by 0.30%, and the 30-year main contract rose by 0.30%, a record high. The 10-year main contract rose by 0.12%, the 5-year main contract rose by 0.05% and the 2-year main contract rose by 0.02%.

In response to Trump's tariff threat, some Canadian governors supported the "cut-off" of energy products to the United States. Canadian Prime Minister Trudeau and provincial governors held another meeting on December 11 local time to discuss the tariff threat of US President-elect Trump. After the meeting, Canadian Deputy Prime Minister and Minister of Finance Christia freeland told the media that "many governors strongly supported Canada to take strong countermeasures, and some of them took the initiative to list the key minerals and metals produced in their provinces and exported to the United States." Doug Ford, Governor of Ontario, Canada, said after the meeting that if the United States insists on imposing tariffs on Canada, Ontario will "cut off" the energy supply to the United States. He said, "We will cut off the energy supply to Michigan, New York and Wisconsin." Ford also believes that Canada needs to "prepare for the battle" and Trump's tariff will be "100%". (CCTV News)Malaysia established the National Office of Artificial Intelligence Policies and Regulations.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.